Visa Interest Paid decreased by 77.5% to $48.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $48.00M to $48.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows relatively stable performance with a -2.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $243.00M | $60.00M | $244.00M | $60.00M | $244.00M | $59.00M | $244.00M | $49.00M | $275.00M | $49.00M | $213.00M | $48.00M | $273.00M | $49.00M | $213.00M | $48.00M | $278.00M | $48.00M | $213.00M | $48.00M |
| QoQ Change | — | -75.3% | +306.7% | -75.4% | +306.7% | -75.8% | +313.6% | -79.9% | +461.2% | -82.2% | +334.7% | -77.5% | +468.8% | -82.1% | +334.7% | -77.5% | +479.2% | -82.7% | +343.8% | -77.5% |
| YoY Change | — | — | — | — | +0.4% | -1.7% | +0.0% | -18.3% | +12.7% | -16.9% | -12.7% | -2.0% | -0.7% | +0.0% | +0.0% | +0.0% | +1.8% | -2.0% | +0.0% | +0.0% |